Standard BioTools (NASDAQ: FLDM)
Standard BioTools Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Standard BioTools Company Info
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
News & Analysis
Valuation
Earnings Transcripts
Fluidigm (FLDM) Q1 2020 Earnings Call Transcript
FLDM earnings call for the period ending March 31, 2020.
Fluidigm (FLDM) Q4 2019 Earnings Call Transcript
FLDM earnings call for the period ending December 31, 2019.
Fluidigm (FLDM) Q3 2019 Earnings Call Transcript
FLDM earnings call for the period ending September 30, 2019.
Fluidigm (FLDM) Q2 2019 Earnings Call Transcript
FLDM earnings call for the period ending June 30, 2019.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.